Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case–cross‐over study

BACKGROUND AND AIMS: Varenicline and nicotine replacement therapy (NRT) are the most commonly used medications to quit smoking. Given their widespread use, monitoring adverse risks remains important. This study aimed to estimate the neuropsychiatric and cardiovascular risks associated with varenicli...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Addiction
Asıl Yazarlar: Thomas, Kyla H., Davies, Neil M., Taylor, Amy E., Taylor, Gemma M. J., Gunnell, David, Martin, Richard M., Douglas, Ian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246946/
https://ncbi.nlm.nih.gov/pubmed/33197082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.15338
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller